Added value of frailty and social support in predicting risk of 30-day unplanned re-admission or death for patients with heart failure: An analysis from OPERA-HF.


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
01 Mar 2019
Historique:
received: 07 06 2018
revised: 16 10 2018
accepted: 10 12 2018
pubmed: 28 12 2018
medline: 23 11 2019
entrez: 28 12 2018
Statut: ppublish

Résumé

Models for predicting the outcome of patients hospitalized for heart failure (HF) rarely take a holistic view. We assessed the ability of measures of frailty and social support in addition to demographic, clinical, imaging and laboratory variables to predict short-term outcome for patients discharged after a hospitalization for HF. OPERA-HF is a prospective observational cohort, enrolling patients hospitalized for HF in a single center in Hull, UK. Variables were combined in a logistic regression model after multiple imputation of missing data to predict the composite outcome of death or readmission at 30 days. Comparisons were made to a model using clinical variables alone. The discriminative performance of each model was internally validated with bootstrap re-sampling. 1094 patients were included (mean age 77 [interquartile range 68-83] years; 40% women; 56% with moderate to severe left ventricular systolic dysfunction) of whom 213 (19%) had an unplanned re-admission and 60 (5%) died within 30 days. For the composite outcome, a model containing clinical variables alone had an area under the receiver-operating characteristic curve (AUC) of 0.68 [95% CI 0.64-0.72]. Adding marital status, support from family and measures of physical frailty increased the AUC (p < 0.05) to 0.70 [95% CI 0.66-0.74]. Measures of physical frailty and social support improve prediction of 30-day outcome after an admission for HF but predicting near-term events remains imperfect. Further external validation and improvement of the model is required.

Sections du résumé

BACKGROUND BACKGROUND
Models for predicting the outcome of patients hospitalized for heart failure (HF) rarely take a holistic view. We assessed the ability of measures of frailty and social support in addition to demographic, clinical, imaging and laboratory variables to predict short-term outcome for patients discharged after a hospitalization for HF.
METHODS METHODS
OPERA-HF is a prospective observational cohort, enrolling patients hospitalized for HF in a single center in Hull, UK. Variables were combined in a logistic regression model after multiple imputation of missing data to predict the composite outcome of death or readmission at 30 days. Comparisons were made to a model using clinical variables alone. The discriminative performance of each model was internally validated with bootstrap re-sampling.
RESULTS RESULTS
1094 patients were included (mean age 77 [interquartile range 68-83] years; 40% women; 56% with moderate to severe left ventricular systolic dysfunction) of whom 213 (19%) had an unplanned re-admission and 60 (5%) died within 30 days. For the composite outcome, a model containing clinical variables alone had an area under the receiver-operating characteristic curve (AUC) of 0.68 [95% CI 0.64-0.72]. Adding marital status, support from family and measures of physical frailty increased the AUC (p < 0.05) to 0.70 [95% CI 0.66-0.74].
CONCLUSIONS CONCLUSIONS
Measures of physical frailty and social support improve prediction of 30-day outcome after an admission for HF but predicting near-term events remains imperfect. Further external validation and improvement of the model is required.

Identifiants

pubmed: 30587417
pii: S0167-5273(18)33656-8
doi: 10.1016/j.ijcard.2018.12.030
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

167-172

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

I Sokoreli (I)

Philips Research - Healthcare, Eindhoven, the Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: ioanna.sokoreli@philips.com.

J G Cleland (JG)

University of Hull, Hull, UK; National Heart & Lung Institute, Imperial College, London, UK; London and Robertson Centre for Biostatistics & Clinical Trials, University of Glasgow, UK.

S C Pauws (SC)

Philips Research - Healthcare, Eindhoven, the Netherlands; TiCC - University of Tilburg, Tilburg, the Netherlands.

E W Steyerberg (EW)

Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands; Department of Public Health, Erasmus MC, Rotterdam, the Netherlands.

J J G de Vries (JJG)

Philips Research - Healthcare, Eindhoven, the Netherlands.

J M Riistama (JM)

Philips Research - Healthcare, Eindhoven, the Netherlands.

K Dobbs (K)

Castle Hill Hospital, Hull, UK.

J Bulemfu (J)

Castle Hill Hospital, Hull, UK.

A L Clark (AL)

University of Hull, Hull, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH